about
Prostaglandins regulate the synthesis and secretion of the atrial natriuretic peptideAtrial natriuretic peptide transcription, secretion, and glomerular receptor activity during mineralocorticoid escape in the rat.Atrial natriuretic factor reduces cyclic adenosine monophosphate content of human fibroblasts by enhancing phosphodiesterase activity.Effects of atrial natriuretic factor on cyclic guanosine monophosphate and cyclic adenosine monophosphate accumulation in microdissected nephron segments from rats.Developmental changes in the rat atriopeptin hormonal system.Role of atrial natriuretic peptide in adaptation of sodium excretion with reduced renal massAtrial natriuretic factor and postnatal diuresis in respiratory distress syndromeMechanisms and amelioration of acute renal allograft failure in the cyclosporine era.Atrial natriuretic peptide protects against acute ischemic renal failure in the ratInteraction of atriopeptin III and vasopressin on calcium kinetics and contraction of aortic smooth muscle cells.Effects of atrial natriuretic peptide and vasopressin on chloride transport in long- and short-looped medullary thick ascending limbsRenal effects of TAPP, a highly selective mu-opioid agonistRenal actions of atrial natriuretic factor: a mathematical modeling study.Corticotropin-releasing hormone causes antidiuresis and antinatriuresis by stimulating vasopressin and inhibiting atrial natriuretic peptide release in male ratsInfluence of neuropeptides on airway smooth muscle.Physiologic and pharmacologic studies of atrial natriuretic factor: a natriuretic and vasoactive peptide.Dissociation of natriuresis and diuresis and heterogeneity of the effector system of atrial natriuretic factor in rats.Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.Influence of parathyroidectomy on blood pressure and vascular reactivity in spontaneously hypertensive rats.Regulation of the atrial natriuretic peptide receptor on a smooth muscle cell.Atrial natriuretic factor and sodium nitroprusside increase cyclic GMP in cultured rat lung fibroblasts by activating different forms of guanylate cyclase.Rapid receptor-mediated catabolism of 125I-atrial natriuretic factor by vascular endothelial cellsAtrial-natriuretic-factor mRNA is developmentally regulated in heart ventricles and actively expressed in cultured ventricular cardiac muscle cells of rat and human.Characterization of ANF receptors in cultured renal cortical vascular smooth muscle cells.Atrial natriuretic peptide in volume expansion-induced natriuresis in man.The heart is an endocrine gland.Vascular responses to local atrial natriuretic peptide infusion in man.ANP relaxes bovine tracheal smooth muscle and increases cGMP.Aziridine-Mediated Ligation at Phenylalanine and Tryptophan Sites.Fetal expression of renin, angiotensinogen, and atriopeptin genes in chick heart.Hemodynamic interactions of atrial natriuretic factor with the sympathetic nervous system in sheep.The effect of different exercise-testing protocols on atrial natriuretic peptide
P2860
Q34254987-D78F689C-EB30-4126-AD0D-91F4982D971EQ34539673-FAA2F8D6-9EE0-46FA-954C-1F0F77EEE58EQ34558768-6F0982BB-B52F-47E9-8372-43CF31AFAF1AQ34559781-6D7F3807-A343-4FC1-9F18-042604C36757Q34570295-FFF25A16-35D9-4744-9FC7-E6D2EE053C8FQ34575790-CEEEAF55-EDF6-4E33-975E-FAAA12586E19Q35066644-BCC603CF-F893-405C-BF50-948EEC735531Q35349065-436C327A-A587-4775-8E84-DB75678FE450Q35581033-DE047A48-6AA9-4330-9AEC-EEF65F18BA22Q35592007-1F2B0602-4A9A-41DB-BFE0-62E7888E6630Q35604747-E0181C6A-255B-4AA5-9A4A-D12D90F50392Q35884692-89FBB5B0-144F-43EC-941F-7F1465EEA5F9Q36661856-59ECD433-0BC3-4374-8B6F-30842DF94BC3Q37158070-6A1641CB-4D17-46D9-B030-FD29B6001465Q38182077-B20DCDE1-97CA-4ADB-AB2F-9464DEB6D9D8Q39485013-F1C8FD34-97A4-46F9-BA33-233D5CBED21DQ40378674-FB33DB0C-A5C4-47B1-B38D-C26821D18FA0Q40919655-36617871-25B5-4EBB-991B-78E04CE78AA0Q41286050-E8E05BF3-E08A-436E-BD8F-35110D4FFF42Q41333465-548F2530-3944-4266-93E0-3D6CB6DADBF0Q41808548-725D0D31-A3C6-4404-BE67-B7ED7EB80FF4Q41943759-D42792E4-2CB1-43C5-9677-DCF8DA15CC1AQ41953951-5C534D0B-C610-4934-8D59-6CC15EC22D2AQ42466418-AC6EE77E-241A-4C90-A141-6A4679E64D4DQ42506328-83E36784-64C3-4EF6-9460-A999671AC2A8Q43094578-D5A795E5-836F-4BB0-B6E4-38FF1BFA0939Q43229256-8F22DE09-0EC6-4C24-B131-0621622386F7Q43855265-472B9F4B-0C75-4FA4-B881-0CCD6662AA3AQ48793448-EABDB779-2D58-4295-BC14-58D09E0D64DDQ52243469-6EF60DA5-4FEB-4C2E-BD36-D56FEE5C010DQ54338046-531ECA31-A8C2-4465-9CA6-4EB75EE8CC2DQ57590440-26A3655C-F1D9-4B51-A994-316AE72440CE
P2860
description
1985 nî lūn-bûn
@nan
1985 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Biologically active atrial peptides.
@ast
Biologically active atrial peptides.
@en
Biologically active atrial peptides.
@nl
type
label
Biologically active atrial peptides.
@ast
Biologically active atrial peptides.
@en
Biologically active atrial peptides.
@nl
prefLabel
Biologically active atrial peptides.
@ast
Biologically active atrial peptides.
@en
Biologically active atrial peptides.
@nl
P2860
P356
P1476
Biologically active atrial peptides.
@en
P2093
B J Ballerman
B M Brenner
P2860
P304
P356
10.1172/JCI112206
P407
P577
1985-12-01T00:00:00Z